Registry for Combined Gastric Mucosal Ablation with Endoscopic Sleeve Gastroplasty for Weight Loss
This study is looking at the results of a procedure called combined gastric mucosal ablation with endoscopic sleeve gastroplasty for adults with obesity. This procedure involves using an endoscope (a thin, flexible tube with a camera) to reshape the stomach and also perform an ablation (a procedure that uses heat or cold to remove tissue) on the stomach lining. The main goal is to see how much weight participants lose, specifically the percentage change in their total body weight after 12 months. You might be able to join if you are between 18 and 65 years old and have a BMI (Body Mass Index) between 28 and 55. The study is currently collecting information, but its exact status for new participants is unclear.
- Study design
- This is an observational study that plans to enroll 100 participants. It is designed to collect information on the outcomes of the procedure.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint is measured at 12 months, which suggests participants will be followed for at least one year after the procedure.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Ablation Registry (Combined Gastric Mucosal Ablation With Endoscopic Sleeve Gastroplasty for Weight Loss)
At a glance
Conditions
Where it's being run
2 sites across 2 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Percent Change in Total Body Weight Loss (TBWL) from Baseline12 Months
Measured percent change in total body weight over time following combined Gastric Mucosal Ablation. %TBWL = (pre-op weight - post op body weight) / (pre-op weight) \* 100 measured as a percentage.